Announcement
GENERAL: AFT: RooLife ASX announcement
12:38pm
AFT
10/07/2020 12:38
GENERAL
NOT PRICE SENSITIVE
REL: 1238 HRS AFT Pharmaceuticals Limited
GENERAL: AFT: RooLife ASX announcement
The attached ASX release by RooLife (ASX:RLG) is related to AFT and has
therefore been attached to our ASX ticker AFP.
Accordingly we now make the RooLife release available on our NZX ticker.
Issued for and on behalf of AFT Pharmaceuticals Limited by Malcolm Tubby,
Chief Financial Officer.
10 July 2020
RooLife & AFT launch Online New Zealand Health Store in China
o RooLife partners with ASX & NZX-listed AFT Pharmaceuticals (ASX:AFP,
NZX:AFT) to deliver New Zealand branded online health & pharmacy store in
China
o "Kiwi Health" will be the online marketplace in China for AFT
Pharmaceuticals' high-profile, well-known and trusted portfolio of health and
wellbeing products
o RooLife to provide digital marketing, e-Commerce operation and sales in
China
o "Kiwi Health" will expand RooLife's and AFT's revenue streams on Alibaba's
Tmall and Alipay's platform with health products expected to be in strong
demand
o Three-year contract expected to deliver revenue of $2.2 million to RooLife
based on services fees and annual sales targets being met
o Latest agreement takes the value of RooLife's announced contract wins since
March 2020 to $6 million in value, subject to minimum annual sales targets
being met for each respective contract .
o RooLife Q4 FY2020 unaudited Revenue of $1m+ (up +25% over prior Quarter)
during challenging market conditions
o RooLife is now marketing and selling products in China from Australia, New
Zealand, U.S.A. and United Kingdom
o Third RooLife Tmall store appointment and launch secured in the last 4
months
e-Commerce marketing and Artificial Intelligence (AI) company RooLife Group
Ltd (ASX:RLG) ("RooLife") is delighted to be appointed by ASX and NZX listed
AFT Pharmaceuticals ("AFT") to launch and operate a New Zealand branded
health & pharmacy store selling key AFT products on Alibaba's Tmall platform.
The three-year contract expands RooLife's Alibaba Tmall revenues and provides
RooLife a mixture of monthly service fees and product sales revenue from
marketing and selling products within the AFT range.
The contract, which is subject to ongoing sales performance milestones, is
expected to deliver total revenue for the RooLife Group of approximately
$2.2m over a three year period if minimum sales targets, which are scaled up
each year, are met.
The new Kiwi Health store will market and sell a range of health and
well-being products online in China leveraging the strong brand awareness of
AFT's product range using the "Kiwi's thinking about health" branding.
Kiwi Health Tmall Store Launching on Alibaba - "Kiwi's thinking about health"
AFT Founder and CEO, Dr Hartley Atkinson says that he is very pleased to
further extend the company's offering to consumers via Online China, "With a
population of over 1.4 billion1 (2020), and with our products already having
a strong following by the local Chinese consumer living in New Zealand, we
believe that a Tmall flagship store along with amplifying our online presence
in China, represents great potential for our health and well-being
portfolio's future growth," said Dr Atkinson.
RooLife Managing Director, Bryan Carr commented, "Working with AFT
Pharmaceuticals to market and sell their well-known, trusted portfolio of
health and wellbeing products in the Chinese market under the Kiwi Health
banner is an attractive growth opportunity for RooLife.
We have seen the successes achieved by large Australian and NZ based pharmacy
chains online in China and we are excited by the opportunity available with
AFT Pharmaceuticals' range of products, leveraging the high regard for New
Zealand and its products with Chinese shoppers."
The latest contract is expected to contribute to the continued revenue growth
RooLife has achieved in the last 18 months with growth of 490% achieved in
FY19 and 380% achieved in FY20.
Continuing to build on the strong revenue base achieved in Financial Year
2020, RooLife has announced three new contract wins totalling $6 million in
revenue expected this year and over the next two years, subject to the
respective minimum sales performance milestones being met.
RooLife Strong Year-on-Year Revenue Growth (*Based on minimum sales
performance milestones)
RooLife has achieved strong revenue growth this year with unaudited revenue
of over $1 million for the Quarter ended 30 June 2020 and we are seeing solid
demand for health and well-being products such as those provided by AFT and
we expect this new agreement to contribute to further sales growth this
financial year.
The RooLife platform provides an international gateway for products and
services for companies wishing to enter the China market. RooLife is now
representing and driving sales for a growing number of quality products and
brand names into China for companies from Australia, New Zealand, U.S.A and
the United Kingdom."
ENDS
1. Source: www.worldometers.info/world-population/china-population
Issued by: RooLife Group Ltd
Authorised by: The Board of RooLife Group Ltd
For further information, please visit the RooLife website at
www.roolifegroup.com.au and www.aftpharm.co.nz or contact:
Bryan Carr
Managing Director
Ph: +61 8 6444 1702
Email: ir@roolifegroup.com.au
Peter Nesveda
Corporate Affairs & International Investor Relations
Ph: +61 412 357 375
peter@intuitiveaustralia.com.au
Sarah Lenard - Advisir
Investor Relations/Media Contact
Telephone: +61 432 332 905
Email: sarah.lenard@advisir.com.au
About RooLife Group Ltd (ASX:RLG)
www.roolifegroup.com.au
The RooLife Group of companies provides fully integrated digital marketing
and customer acquisition services focusing on driving online sales of
products and services for its clients. Powered by the Group's hyper
personalisation and profiling Artificial Intelligence System, RooLife
provides personalised real-time, targeted marketing. With a key focus on
driving sales in Australia and China the company's online e-Commerce
marketplace assists businesses to sell directly to Chinese consumers and
accept payment via the WeChat and Alipay mobile payments platforms. RooLife's
key positioning is about knowing and remaining connected with Chinese
consumers, allowing brands to continually sell products to Chinese consumers
based on their profiles and purchasing behaviours.
New Contract Revenue FY21+*
Nurea Beauty $1.3m
Colab $2.5m
Kiwi Health $2.2m
TOTAL $6.0m
About AFT Pharmaceuticals (ASX:AFP, NZX:AFT)
www.aftpharm.com
AFT Pharmaceuticals are a growing multinational pharmaceutical company that
develops, markets and distributes a broad portfolio of pharmaceutical
products across a wide range of therapeutic categories which are distributed
across all major pharmaceutical distribution channels: over-the-counter,
prescription and hospital. AFT's product portfolio comprises both proprietary
and in-licensed products, and includes patented, branded and generic drugs.
End CA:00356091 For:AFT Type:GENERAL Time:2020-07-10 12:38:31
Click here
to view related attachments.
